1. Home
  2. ANL vs ODD Comparison

ANL vs ODD Comparison

Compare ANL & ODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

SELL

Current Price

$10.00

Market Cap

998.8M

Sector

N/A

ML Signal

SELL

Logo ODDITY Tech Ltd.

ODD

ODDITY Tech Ltd.

HOLD

Current Price

$15.53

Market Cap

973.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANL
ODD
Founded
2004
2018
Country
Singapore
Israel
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
998.8M
973.7M
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
ANL
ODD
Price
$10.00
$15.53
Analyst Decision
Strong Buy
Hold
Analyst Count
7
11
Target Price
★ $29.50
$16.94
AVG Volume (30 Days)
229.1K
★ 838.0K
Earning Date
08-14-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$243.83
N/A
Revenue Next Year
N/A
$11.75
P/E Ratio
★ N/A
$16.73
Revenue Growth
N/A
N/A
52 Week Low
$0.88
$9.25
52 Week High
$17.25
$46.45

Technical Indicators

Market Signals
Indicator
ANL
ODD
Relative Strength Index (RSI) 41.78 34.39
Support Level $8.95 $11.51
Resistance Level $11.75 $15.72
Average True Range (ATR) 1.03 1.90
MACD 0.20 -0.73
Stochastic Oscillator 42.35 2.35

Price Performance

Historical Comparison
ANL
ODD

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

About ODD ODDITY Tech Ltd.

ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage. Geographically, the company generates majority revenue from United states followed by other countries and Israel.

Share on Social Networks: